Farrukh M Koraishy
Farrukh M Koraishy is an expert in Nephrology at Stony Brook University (United States). Farrukh M Koraishy has authored 105 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 345 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Infectiology - Public Health - Pulmonology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Farrukh M. Koraishy, MD, PhD, FASN, is Professor of Medicine in the Division of Nephrology and Hypertension at Stony Brook University. His research focuses on chronic kidney disease (CKD), acute kidney injury (AKI), geriatric kidney disease, and the kidney–brain and mental health axis, with particular interest in cognitive impairment, PTSD, kidney function decline, and outcomes in older and other high-risk populations.
His work integrates longitudinal clinical cohorts, national real-world data, target trial emulation, causal inference, natural language processing, and machine learning to study kidney disease progression and therapeutic strategies. He has led and collaborated on research involving the National COVID Cohort Collaborative (N3C), World Trade Center responders, and studies of CKD in older adults, including relationships between kidney disease, geriatric assessments, cognition, and clinical outcomes. He has received research support from NIH, CDC/NIOSH, Dialysis Clinic Inc., and SUNY and is particularly interested in collaborative clinical research, pragmatic trials, real-world evidence, precision medicine, and healthy aging in kidney diseas
Organizations
Career arc: 2013 - 2025
Number : 105
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Increasing Multimorbidity Burden After COVID-19 Infection Among People With and Without HIV in the United States: Insights From the National Clinical Cohort Collaborative (N3C). PMID 42787535 — comorbidity, covid-19, multimorbidity, diagnosis, infections | Open Forum Infect Dis | 2026 | 0 |
| Updated COVID-19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions. PMID 42712104 — hospitalization, vaccines, covid-19 vaccines, extracorporeal membrane oxygenation, arthritis, rheumatic diseases, vaccination, covid-19, ventilation | Arthritis Rheumatol | 2026 | 0 |
| COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID. PMID 42497651 — vaccines, biomedical research, vaccination, covid-19, odds ratio, post-acute covid-19 syndrome | EBioMedicine | 2026 | 0 |
| Immune Priming and the Risk of COVID-19, Influenza, and Other Acute Respiratory Infections: Insights From an N3C Cohort. PMID 41867090 — viral interference, vaccines, respiratory tract infections, vaccination, covid-19, influenza, human, influenza vaccines, infections | Influenza Other Respir Viruses | 2026 | 0 |
| Post-nephrectomy outcomes in COVID-19 and non-COVID-19 Patients using ACEi, ARB and SGLT2i: a N3C database study. PMID 41795760 — kidney diseases, urology, nephrectomy, covid-19, gout, infections | Int Urol Nephrol | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 36
LeadR Networks
Main global connection map